吡咯他尼结构式
|
常用名 | 吡咯他尼 | 英文名 | Piretanide |
|---|---|---|---|---|
| CAS号 | 55837-27-9 | 分子量 | 362.40000 | |
| 密度 | 1.415 g/cm3 | 沸点 | 597.7ºC at 760 mmHg | |
| 分子式 | C17H18N2O5S | 熔点 | 225-227°C (lit.) | |
| MSDS | N/A | 闪点 | 315.3ºC |
吡咯他尼用途吡雷他尼是一种口服活性、相对安全有效的利尿剂。吡雷他尼有可能用于充血性心力衰竭的研究,其潜在优势是具有保钾特性。吡雷他尼也可用于高血压的研究[1][2]。 |
| 中文名 | 吡咯他尼 |
|---|---|
| 英文名 | 4-phenoxy-3-pyrrolidin-1-yl-5-sulfamoylbenzoic acid |
| 中文别名 | 4-苯氧基-3-吡咯烷-1-基-5-氨基磺酰基苯甲酸 | 苯氧吡酸 |
| 英文别名 | 更多 |
| 描述 | 吡雷他尼是一种口服活性、相对安全有效的利尿剂。吡雷他尼有可能用于充血性心力衰竭的研究,其潜在优势是具有保钾特性。吡雷他尼也可用于高血压的研究[1][2]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.415 g/cm3 |
|---|---|
| 沸点 | 597.7ºC at 760 mmHg |
| 熔点 | 225-227°C (lit.) |
| 分子式 | C17H18N2O5S |
| 分子量 | 362.40000 |
| 闪点 | 315.3ºC |
| 精确质量 | 362.09400 |
| PSA | 118.31000 |
| LogP | 4.27080 |
| InChIKey | UJEWTUDSLQGTOA-UHFFFAOYSA-N |
| SMILES | NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1 |
| 外观性状 | 淡黄色粉末 |
| 折射率 | 1.64 |
| 储存条件 | 2-8°C |
| 海关编码 | 2935009090 |
|---|
| 海关编码 | 2935009090 |
|---|---|
| 中文概述 | 2935009090 其他磺(酰)胺. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:35.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
|
Role of EDHF in the vasodilatory effect of loop diuretics in guinea-pig mesenteric resistance arteries.
Br. J. Pharmacol. 131(6) , 1211-9, (2000) 1. Relaxing effect of loop diuretics, piretanide and furosemide in comparison with acetylcholine (ACh) was investigated in guinea-pig isolated mesenteric resistance arteries. 2. Concentration-response... |
|
|
Modulation of chloride, potassium and bicarbonate transport by muscarinic receptors in a human adenocarcinoma cell line.
Br. J. Pharmacol. 126(1) , 269-79, (1999) 1. Short-circuit current (I(SC)) responses to carbachol (CCh) were investigated in Colony 1 epithelia, a subpopulation of the HCA-7 adenocarcinoma cell line. In Krebs-Henseleit (KH) buffer, CCh respon... |
|
|
Fc epsilon RI-mediated chloride uptake by rat mast cells: modulation by chloride transport inhibitors in relation to histamine secretion.
Br. J. Pharmacol. 122(6) , 1188-94, (1997) 1. We have examined the role of extracellular chloride in the mast cell secretion process. The immunologically-directed ligand, antibody to IgE (anti-IgE) required extracellular chloride ions for opti... |
|
实验名称:Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
来源:NCGC
External Id:SNCA-p-activity-luciferase
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
来源:824
External Id:CYP273
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify pos...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
来源:NCGC
External Id:HERG01
|
|
实验名称:uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
来源:Burnham Center for Chemical Genomics
靶标:cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id:SBCCG-A764-CF-PAF-Primary-Assay
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ant...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_ANT_FLUO8_1536_1X%INH PRUN
|
|
实验名称:Primary qHTS for inhibitors of NSP2Pro chikungunya virus (CHIKV)
来源:NCGC
External Id:APP-Toga-CHIKV-nsp2-p
|
| Tauliz |
| Piretanido [Spanish] |
| Piretanido [INN-Spanish] |
| Hoe-118 |
| Piretanidum [INN-Latin] |
| MFCD00867334 |
| 4-phenoxy-3(1-pyrrolidinyl)-5-sulfamoylbenzoic acid |
| EINECS 259-852-9 |
| 4-phenoxy-3-(pyrrolidin-1-yl)-5-sulfamoylbenzoic acid |
| Arelix (TN) |
| piretanide |
| 3-(1-pyrrolidinyl)-4-phenoxy-5-sulfamylbenzoic acid |